{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T09:36:39Z","timestamp":1790847399391,"version":"4.1.0"},"reference-count":43,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,12]]},"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Kawasaki disease (KD) is the most common cause of acquired heart disease in American children. Intravenous immunoglobulin (IVIG) nonresponse is a known risk factor for cardiac sequelae. Previously reported risk factors for nonresponse include age, male sex and laboratory abnormalities. We set out to identify additional risk factors for IVIG nonresponse in a racially diverse KD population.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>We conducted a retrospective chart review at a referral center in the Southeastern United States of children meeting ICD-9 (International Statistical Classification of Disease and Related Health Problems) criteria for KD and being treated with IVIG.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>Four-hundred and fifty-nine children met inclusion criteria, 67 were excluded for subsequent rheumatologic diagnosis, unknown race, or failure to meet the American Heart Association guideline criteria. Our final cohort consisted of 392 subjects, with median age of 2.7 years, 65.1% male, 66.1% White, 24.2% Black, 4.9% Asian and 82.9% responded to a single dose of IVIG. Coronary ectasia or aneurysm developed in 27%; 7.4% developed aneurysms and 2.3% giant coronary aneurysms. Nonresponders were more likely to be Black, have higher white blood cell, erythrocyte sedimentation rate and C-reactive protein, lower hemoglobin, develop ectasia or aneurysm and require critical care and hospital readmission. Responders achieved echocardiographic normalization more often compared with nonresponders (81.3% vs. 60.9%, <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.002) and coronary artery pseudonormalization (87.2% vs. 69.7%, <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.03) at 1 year. Black nonresponders had the slowest normalization at 1 year (52.9%, <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.02).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>Nonresponders have higher rates and greater severity of coronary involvement than responders. Our study uniquely demonstrates Black race as a risk factor for nonresponse and for delayed normalization of cardiac involvement at 1-year follow-up.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/inf.0000000000002019","type":"journal-article","created":{"date-parts":[[2018,3,22]],"date-time":"2018-03-22T14:17:52Z","timestamp":1521728272000},"page":"1227-1234","source":"Crossref","is-referenced-by-count":26,"title":["Predictors of Intravenous Immunoglobulin Nonresponse and Racial Disparities in Kawasaki Disease"],"prefix":"10.1097","volume":"37","author":[{"given":"Daniel E.","family":"Clark","sequence":"first","affiliation":[{"name":"Departments of Internal Medicine and Pediatrics, Vanderbilt University Medical Center, Nashville, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kara J.","family":"Denby","sequence":"additional","affiliation":[{"name":"Departments of Internal Medicine and Pediatrics, Vanderbilt University Medical Center, Nashville, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura M.","family":"Kaufman","sequence":"additional","affiliation":[{"name":"Greater Lawrence Family Health Center, Lawrence, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary-Margaret A.","family":"Fill","sequence":"additional","affiliation":[{"name":"Tennessee Department of Health"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhinnata","family":"Piya","sequence":"additional","affiliation":[{"name":"Division of Pediatric Infectious Disease, Department of Pediatrics, Vanderbilt University Medical Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanthi","family":"Krishnaswami","sequence":"additional","affiliation":[{"name":"Division of Pediatric Infectious Disease, Department of Pediatrics, Vanderbilt University Medical Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Fonnesbeck","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, Vanderbilt University, Nashville, Tennessee."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natasha","family":"Halasa","sequence":"additional","affiliation":[{"name":"Division of Pediatric Infectious Disease, Department of Pediatrics, Vanderbilt University Medical Center"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230912","doi-asserted-by":"crossref","first-page":"e927","DOI":"10.1161\/CIR.0000000000000484","article-title":"Diagnosis, treatment, and long-term management of Kawasaki disease: a Scientific Statement for Health Professionals from the American Heart Association.","volume":"135","author":"McCrindle","year":"2017","journal-title":"Circulation"},{"key":"R2-20230912","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S0140-6736(04)16814-1","article-title":"Kawasaki syndrome.","volume":"364","author":"Burns","year":"2004","journal-title":"Lancet"},{"key":"R3-20230912","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1542\/peds.112.3.495","article-title":"Kawasaki syndrome hospitalizations in the United States, 1997 and 2000.","volume":"112","author":"Holman","year":"2003","journal-title":"Pediatrics"},{"key":"R4-20230912","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1056\/NEJM199106063242305","article-title":"A single intravenous infusion of gamma globulin as compared with four infusions in the treatment of acute Kawasaki syndrome.","volume":"324","author":"Newburger","year":"1991","journal-title":"N Engl J Med"},{"key":"R5-20230912","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1097\/00006454-199812000-00009","article-title":"Intravenous gamma-globulin treatment and retreatment in Kawasaki disease. US\/Canadian Kawasaki Syndrome Study Group.","volume":"17","author":"Burns","year":"1998","journal-title":"Pediatr Infect Dis J"},{"key":"R6-20230912","doi-asserted-by":"crossref","first-page":"427","DOI":"10.2188\/jea.JE20140018","article-title":"Epidemiologic features and prognostic factors of coronary artery lesions associated with Kawasaki disease based on a 13-year cohort of consecutive cases identified by complete enumeration surveys in Wakayama, Japan.","volume":"24","author":"Kitano","year":"2014","journal-title":"J Epidemiol"},{"key":"R7-20230912","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jpeds.2007.12.021","article-title":"Resistance to intravenous immunoglobulin in children with Kawasaki disease.","volume":"153","author":"Tremoulet","year":"2008","journal-title":"J Pediatr"},{"key":"R8-20230912","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1542\/peds.88.6.1144","article-title":"Cardiac sequelae of Kawasaki disease in Japan: statistical analysis.","volume":"88","author":"Nakamura","year":"1991","journal-title":"Pediatrics"},{"key":"R9-20230912","doi-asserted-by":"crossref","first-page":"e1293","DOI":"10.1097\/MJT.0000000000000045","article-title":"Role of the Egami score in predicting intravenous immunoglobulin resistance in Kawasaki disease among different ethnicities.","volume":"23","author":"Loomba","year":"2016","journal-title":"Am J Ther"},{"key":"R10-20230912","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.jpeds.2010.10.031","article-title":"Evaluation of Kawasaki disease risk-scoring systems for intravenous immunoglobulin resistance.","volume":"158","author":"Sleeper","year":"2011","journal-title":"J Pediatr"},{"key":"R11-20230912","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.jpeds.2008.03.014","article-title":"Risk factors for nonresponse to therapy in Kawasaki disease.","volume":"153","author":"Ashouri","year":"2008","journal-title":"J Pediatr"},{"key":"R12-20230912","doi-asserted-by":"crossref","first-page":"e291","DOI":"10.1542\/peds.2011-1704","article-title":"Late intravenous immunoglobulin treatment in patients with Kawasaki disease.","volume":"129","author":"Muta","year":"2012","journal-title":"Pediatrics"},{"key":"R13-20230912","doi-asserted-by":"crossref","first-page":"E66","DOI":"10.1542\/peds.102.6.e66","article-title":"Cardiac sequelae in recurrent cases of Kawasaki disease: a comparison between the initial episode of the disease and a recurrence in the same patients.","volume":"102","author":"Nakamura","year":"1998","journal-title":"Pediatrics"},{"key":"R14-20230912","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1111\/j.1442-200X.2007.02396.x","article-title":"Prevalence of coronary artery abnormality in incomplete Kawasaki disease.","volume":"49","author":"Sonobe","year":"2007","journal-title":"Pediatr Int"},{"key":"R15-20230912","doi-asserted-by":"crossref","first-page":"e10","DOI":"10.1542\/peds.104.1.e10","article-title":"Kawasaki disease: more patients are being diagnosed who do not meet American Heart Association criteria.","volume":"104","author":"Witt","year":"1999","journal-title":"Pediatrics"},{"key":"R16-20230912","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1542\/peds.2004-2182","article-title":"Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association.","volume":"114","author":"Newburger","year":"2004","journal-title":"Pediatrics"},{"key":"R17-20230912","doi-asserted-by":"crossref","first-page":"e234","DOI":"10.1542\/peds.2009-0606","article-title":"Performance of 2004 American Heart Association recommendations for treatment of Kawasaki disease.","volume":"125","author":"Yellen","year":"2010","journal-title":"Pediatrics"},{"key":"R18-20230912","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research electronic data capture (REDCap)\u2013a metadata-driven methodology and workflow process for providing translational research informatics support.","volume":"42","author":"Harris","year":"2009","journal-title":"J Biomed Inform"},{"key":"R19-20230912","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1136\/heartjnl-2017-311774","article-title":"Management of Kawasaki disease in adults.","volume":"103","author":"Denby","year":"2017","journal-title":"Heart"},{"key":"R20-20230912","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1161\/01.CIR.94.6.1379","article-title":"Long-term consequences of Kawasaki disease. A 10- to 21-year follow-up study of 594 patients.","volume":"94","author":"Kato","year":"1996","journal-title":"Circulation"},{"key":"R21-20230912","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1161\/01.CIR.94.9.2103","article-title":"Endothelial dysfunction late after Kawasaki disease.","volume":"94","author":"Dhillon","year":"1996","journal-title":"Circulation"},{"key":"R22-20230912","doi-asserted-by":"crossref","first-page":"e783","DOI":"10.1542\/peds.2008-1871","article-title":"Recognition of a Kawasaki disease shock syndrome.","volume":"123","author":"Kanegaye","year":"2009","journal-title":"Pediatrics"},{"key":"R23-20230912","first-page":"1593","article-title":"The No-U-Turn Sampler: adaptively setting path lengths in Hamiltonian Monte Carlo.","volume":"15","author":"Hoffman","year":"2014","journal-title":"J Mach Learn Res"},{"key":"R24-20230912","doi-asserted-by":"crossref","first-page":"e55","DOI":"10.7717\/peerj-cs.55","article-title":"Probabilistic programming in Python using PyMC3.","volume":"2","author":"Salvatier","year":"2016","journal-title":"PeerJ Computer Science"},{"key":"R25-20230912","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jpeds.2006.03.050","article-title":"Prediction of resistance to intravenous immunoglobulin treatment in patients with Kawasaki disease.","volume":"149","author":"Egami","year":"2006","journal-title":"J Pediatr"},{"key":"R26-20230912","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.1161\/CIRCULATIONAHA.105.592865","article-title":"Prediction of intravenous immunoglobulin unresponsiveness in patients with Kawasaki disease.","volume":"113","author":"Kobayashi","year":"2006","journal-title":"Circulation"},{"key":"R27-20230912","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1056\/NEJMoa061235","article-title":"Randomized trial of pulsed corticosteroid therapy for primary treatment of Kawasaki disease.","volume":"356","author":"Newburger","year":"2007","journal-title":"N Engl J Med"},{"key":"R28-20230912","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1007\/s00246-014-1016-1","article-title":"Epidemiology of immunoglobulin resistant Kawasaki disease: results from a large, national database.","volume":"36","author":"Moffett","year":"2015","journal-title":"Pediatr Cardiol"},{"key":"R29-20230912","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1001\/jamapediatrics.2016.2055","article-title":"Coronary artery complication in Kawasaki disease and the importance of early intervention: a systematic review and meta-analysis.","volume":"170","author":"Chen","year":"2016","journal-title":"JAMA Pediatr"},{"key":"R30-20230912","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1136\/heartjnl-2012-302126","article-title":"Intravenous immunoglobulin plus corticosteroid to prevent coronary artery abnormalities in Kawasaki disease: a meta-analysis.","volume":"99","author":"Chen","year":"2013","journal-title":"Heart"},{"key":"R31-20230912","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1177\/000992280504400812","article-title":"Kawasaki disease hospitalizations in a predominantly African-American population.","volume":"44","author":"Abuhammour","year":"2005","journal-title":"Clin Pediatr (Phila)"},{"key":"R32-20230912","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1001\/archpedi.156.5.492","article-title":"An evaluation of hospitalizations for Kawasaki syndrome in Georgia.","volume":"156","author":"Gibbons","year":"2002","journal-title":"Archives of Pediatric and Adolescent Medicine"},{"key":"R33-20230912","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1007\/s00246-005-0916-5","article-title":"The epidemiology of Kawasaki disease in an urban hospital: does African American race protect against coronary artery aneurysms?","volume":"26","author":"Porcalla","year":"2005","journal-title":"Pediatr Cardiol"},{"key":"R34-20230912","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1038\/nri2762","article-title":"FcgammaRIIB in autoimmunity and infection: evolutionary and therapeutic implications.","volume":"10","author":"Smith","year":"2010","journal-title":"Nat Rev Immunol"},{"key":"R35-20230912","doi-asserted-by":"crossref","first-page":"e1005456","DOI":"10.1371\/journal.ppat.1005456","article-title":"Antigen-specific antibody glycosylation is regulated via vaccination.","volume":"12","author":"Mahan","year":"2016","journal-title":"PLoS Pathog"},{"key":"R36-20230912","doi-asserted-by":"crossref","first-page":"e81448","DOI":"10.1371\/journal.pone.0081448","article-title":"Treatment response in Kawasaki disease is associated with sialylation levels of endogenous but not therapeutic intravenous immunoglobulin G.","volume":"8","author":"Ogata","year":"2013","journal-title":"PLoS One"},{"key":"R37-20230912","doi-asserted-by":"crossref","first-page":"820","DOI":"10.3390\/ijms18040820","article-title":"Anemia in Kawasaki disease: Hepcidin as a potential biomarker.","volume":"18","author":"Huang","year":"2017","journal-title":"Int J Mol Sci"},{"key":"R38-20230912","doi-asserted-by":"crossref","first-page":"93","DOI":"10.3945\/ajcn.2010.29185","article-title":"Randomized, double-blind, placebo-controlled trial of an iron-fortified food product in female soldiers during military training: relations between iron status, serum hepcidin, and inflammation.","volume":"92","author":"Karl","year":"2010","journal-title":"Am J Clin Nutr"},{"key":"R39-20230912","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1017\/S0007114515000999","article-title":"Vitamin D deficiency is associated with anaemia among African Americans in a US cohort.","volume":"113","author":"Smith","year":"2015","journal-title":"Br J Nutr"},{"key":"R40-20230912","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1097\/00006454-199306000-00010","article-title":"Efficacy of plasmin-treated intravenous gamma-globulin for therapy of Kawasaki syndrome.","volume":"12","author":"Hsu","year":"1993","journal-title":"Pediatr Infect Dis J"},{"key":"R41-20230912","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s10238-005-0079-y","article-title":"Immunomodulation of autoimmune and inflammatory diseases with intravenous immunoglobulin.","volume":"5","author":"Ephrem","year":"2005","journal-title":"Clin Exp Med"},{"key":"R42-20230912","doi-asserted-by":"crossref","first-page":"e1434","DOI":"10.1542\/peds.2007-0815","article-title":"Delayed diagnosis of Kawasaki disease: what are the risk factors?","volume":"120","author":"Minich","year":"2007","journal-title":"Pediatrics"},{"key":"R43-20230912","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1097\/INF.0b013e31815922b5","article-title":"Analysis of potential risk factors associated with nonresponse to initial intravenous immunoglobulin treatment among Kawasaki disease patients in Japan.","volume":"27","author":"Uehara","year":"2008","journal-title":"Pediatr Infect Dis J"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00006454-201812000-00006","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,12]],"date-time":"2023-09-12T23:08:33Z","timestamp":1694560113000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006454-201812000-00006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":43,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0000000000002019","relation":{},"ISSN":["0891-3668"],"issn-type":[{"value":"0891-3668","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]}}}